Officinalisinin I | CAS:57944-18-0 | Manufacturer ChemFaces

Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC

Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

J Biochem Mol Toxicol.2020, 34(7):e22489.

Pharmacol Res.2020, 161:105205.

Molecules.2017, 22(2)

TCI CO.2019, US20190151257A1

Int J Mol Sci.2022, 23(10):5468.

Appl. Sci.2021, 11(1),14.

Molecules.2024, 29(3):671.

Exp Parasitol.2015, 153:160-4

Toxicol In Vitro.2024, 99:105876.

Journal of Life Science2017, 233-240

China Journal of Traditional Chinese Medicine & Pharmacy, 2017 (2) :782-785.

Study on hypoglycemic mechanism and central nerve protection of Officinalisinin Ⅰ in Rhizoma Anemarrhenae[Reference: WebLink]

To study the hypoglycemic effect of Officinalisinin Ⅰin Rhizoma Anemarrhenae on diabetes, and discuss the hypoglycemic mechanism and protective effect on diabetic nephropathy.
METHODS AND RESULTS:
Glucose tolerance was measured in model mice induced by oral administration of alloxan.Inhibition of glycosidase activity was tested in vitro.GLP-1 was detected after fasting in diabetic mice.The levels of BDNF and GSH-PX in serum were detected by enzyme-linked immunosorbent assay(ELISA) after 20 days of medication.Officinalisinin I has the functions of lowering blood glucose and significantly improving the glucose tolerance of diabetic mice.In the experiment, the glycosidase inhibitor pathway was eliminated, andby promoting the generation of GLP-1 and BDNF and increasing the activity of GSH-PX Officinalisinin I achieves the hypoglycemic and neuroprotective effect.
CONCLUSIONS:
Officinalisinin I can effectively reduce the blood glucose and protect nerve injuryin diabetic mice.

Product Name	Officinalisinin I
CAS No.:	57944-18-0
Catalog No.:	CFN90692
Molecular Formula:	C₄₅H₇₆O₁₉
Molecular Weight:	921.07 g/mol
Purity:	>=98%
Type of Compound:	Steroids
Physical Desc.:	Powder
Source:	The rhizomes of Anemarrhena asphodeloides Bunge
Solvent:	DMSO, Pyridine, Methanol, Ethanol, etc.
Price:	$248/20mg